| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 11.072 | 11.279 | 7.465 | 22.051 | 33.748 | 43.304 | 56.924 |
| Total Income - EUR | - | - | - | 11.072 | 11.279 | 7.465 | 25.768 | 33.749 | 43.305 | 56.925 |
| Total Expenses - EUR | - | - | - | 5.187 | 8.787 | 10.185 | 21.991 | 28.189 | 37.777 | 54.796 |
| Gross Profit/Loss - EUR | - | - | - | 5.885 | 2.492 | -2.720 | 3.777 | 5.559 | 5.528 | 2.129 |
| Net Profit/Loss - EUR | - | - | - | 5.552 | 2.153 | -2.942 | 3.199 | 4.668 | 4.443 | 1.690 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Neurofiziologia S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 1.575 | 1.784 | 3.642 | 3.579 | 3.210 |
| Current Assets | - | - | - | 5.517 | 9.259 | 5.814 | 2.650 | 6.387 | 9.281 | 8.264 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 1.604 | 279 | 746 | 1.530 | 3.139 | 2.323 | 423 |
| Cash | - | - | - | 3.913 | 8.980 | 5.068 | 1.120 | 3.248 | 6.958 | 7.842 |
| Shareholders Funds | - | - | - | 5.595 | 7.640 | 4.554 | 3.247 | 7.926 | 12.345 | 13.966 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 137 | 1.619 | 834 | 1.187 | 2.103 | 1.833 | 748 |
| Income in Advance | - | - | - | 0 | 0 | 2.001 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neurofiziologia S.r.l.